Filter Results:
(4,352)
Show Results For
- All HBS Web
(4,352)
- People (14)
- News (1,530)
- Research (2,257)
- Events (1)
- Multimedia (155)
- Faculty Publications (1,769)
Show Results For
- All HBS Web
(4,352)
- People (14)
- News (1,530)
- Research (2,257)
- Events (1)
- Multimedia (155)
- Faculty Publications (1,769)
- 10 Oct 2019
- News
The Case for the Public Option Over Medicare for All
- October 2006 (Revised August 2007)
- Case
Calloway Laboratory: Pee for Profit
By: Richard G. Hamermesh and David Kiron
Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. View Details
Keywords: For-Profit Firms; Health Care and Treatment; Health Testing and Trials; Growth and Development Strategy; Market Entry and Exit; Health Industry
Hamermesh, Richard G., and David Kiron. "Calloway Laboratory: Pee for Profit." Harvard Business School Case 807-040, October 2006. (Revised August 2007.)
- 14 Mar 2016
- Working Paper Summaries
The Role of Incentive Salience in Habit Formation
- July 2002
- Article
The Effect of Decreasing Length of Stay on Discharge Destination and Readmission after Coronary Bypass Operation
By: Richard M.J. Bohmer, John Newell and David F. Torchiana
Bohmer, Richard M.J., John Newell, and David F. Torchiana. "The Effect of Decreasing Length of Stay on Discharge Destination and Readmission after Coronary Bypass Operation." Surgery 132, no. 1 (July 2002): 10–16.
- 22 Jul 2014
- First Look
First Look: July 22
Robert S., and Mary L. Witkowski Abstract—The paper describes the theory and preliminary results for an action research program that explores the implications from better measurements of View Details
Keywords: Sean Silverthorne
- 2018
- Chapter
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new... View Details
Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly
Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.
- June 2023
- Case
Verve Therapeutics: Taking DNA Editing to Heart
By: Shikhar Ghosh and Shweta Bagai
Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details
Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry
Ghosh, Shikhar, and Shweta Bagai. "Verve Therapeutics: Taking DNA Editing to Heart." Harvard Business School Case 823-113, June 2023.
- September 21, 2013
- Other Article
Redefining Global Health-care Delivery
By: Jim Yong Kim, Paul E. Farmer and Michael E. Porter
Initiatives to address the unmet needs of those facing both poverty and serious illness have expanded significantly over the past decade. But many of them are designed in an ad-hoc manner to address one health problem among many; they are too rarely assessed; best... View Details
Keywords: Health
Kim, Jim Yong, Paul E. Farmer, and Michael E. Porter. "Redefining Global Health-care Delivery." Lancet 382, no. 9897 (September 21, 2013).
- September 2016
- Article
Communicating Value in Healthcare Using Radar Charts: A Case Study of Prostate Cancer
By: Nikhil G. Thaker, Tariq N. Ali, Michael E. Porter, Thomas W. Feeley, Robert S. Kaplan and Steven J. Frank
Question: Can we create a value-based tool to visualize the outcomes and cost of various treatments that could facilitate patient-centered decision making?
Summary Answer: We developed a standardized value framework by using radar charts to visualize and... View Details
Summary Answer: We developed a standardized value framework by using radar charts to visualize and... View Details
Thaker, Nikhil G., Tariq N. Ali, Michael E. Porter, Thomas W. Feeley, Robert S. Kaplan, and Steven J. Frank. "Communicating Value in Healthcare Using Radar Charts: A Case Study of Prostate Cancer." Journal of Oncology Practice 12, no. 9 (September 2016): 813–820.
Raymond P. Kluender
Ray Kluender is an assistant professor in the Entrepreneurial Management Unit, teaching Entrepreneurial Finance to second-year MBA students.
He studies the causes of financial distress among American households and how public policy,... View Details
- 11 Oct 2024
- Research & Ideas
How AI Could Ease the Refugee Crisis and Bring New Talent to Businesses
instance, Paulson says she recently had a conversation with an executive MBA student who is designing a platform for matching patients with mental health care providers and... View Details
- January 2006 (Revised April 2007)
- Case
General Electric Healthcare, 2006
By: Tarun Khanna and Elizabeth Raabe
In January 2006, Joe Hogan, head of General Electric (GE) Healthcare Technologies, prepared to step into William Castell's shoes as CEO of GE Healthcare, the world's leading manufacturer of diagnostic imaging equipment. In 2004, former CEO Jeff Immelt acquired Amersham... View Details
Keywords: Corporate Entrepreneurship; Cost vs Benefits; Growth and Development Strategy; Mergers and Acquisitions; Machinery and Machining; Global Range; Multinational Firms and Management; Product Design; Technological Innovation; Expansion; Value Creation; Business Subsidiaries; Health Industry; Health Industry
Khanna, Tarun, and Elizabeth Raabe. "General Electric Healthcare, 2006." Harvard Business School Case 706-478, January 2006. (Revised April 2007.)
- 09 Sep 2020
- News
The Great Experiment
- 03 Mar 2022
- News
Mass General Brigham Ads Touting Expansion Are Ruffling Feathers
- June 1991 (Revised March 1995)
- Case
Becton Dickinson (A): Corporate Strategy
By: Michael Beer
This case series introduces the strategic human resource management (SHRM) process. SHRM is an action research program designed to align the organization and management of human resources with strategy. This case describes the health care industry, Becton Dickinson's... View Details
Keywords: Business or Company Management; Corporate Strategy; Alignment; Human Resources; Health Industry
Beer, Michael. "Becton Dickinson (A): Corporate Strategy." Harvard Business School Case 491-151, June 1991. (Revised March 1995.)
- March 2008
- Case
The Multiple Sclerosis Center of Atlanta
By: Regina E. Herzlinger and Alfred Martin
The Multiple Sclerosis Center of Atlanta wishes to expand beyond Georgia. The factors influencing this decision are discussed, including drug treatments currently available, and the impact of future drugs in the FDA pipeline as well as financing issues. View Details
Keywords: Decision Choices and Conditions; Financing and Loans; Health Care and Treatment; Health Disorders; Medical Specialties; Expansion; Health Industry; Atlanta
Herzlinger, Regina E., and Alfred Martin. "The Multiple Sclerosis Center of Atlanta." Harvard Business School Case 308-085, March 2008.